Drug Stocks are Actively Trading in the Healthcare Sector Today

Through the early part of trading on Tuesday, September 6, 2011, these stocks are very active in the Healthcare (NYSE:XLV) sector. In big news, the FDA rejected Xarelto, a drug co-developed by Johnson & Johnson (NYSE:JNJ) and Bayer.

Popular: Investing in Gold: Is Gold Demand Growing or Shrinking?.

Shares of Johnson & Johnson (NYSE:JNJ) are among the most actively traded stocks in the market. They have a dollar volume today of $318.8 million, based on a current price of $63.24 (-92 cents) and five million shares being traded.

Stock Price Performance: From July 8, 2011, to September 2, 2011, the stock price had fallen $2.90 (-4.3%) from $66.97 to $64.07. The stock price saw one of its best stretches over the last year between September 7, 2010 and September 20, 2010 when shares rose for 10 straight trading days, rising 5.8% (+$3.27). It saw one of its worst periods between July 22, 2011 and August 4, 2011 when shares fell for 10 straight trading days, falling 7.3% (-$4.84).

Shares of Pfizer Inc. (NYSE:PFE) have a dollar volume of $194.9 million based on a current price of $18.24(-22 cents) and 10.7 million shares traded.

Stock Price Performance: From June 9, 2011, to September 2, 2011, the stock price had fallen $2.06 (-10%) from $20.52 to $18.46. The stock price saw one of its best stretches over the last year between April 21, 2011 and May 2, 2011 when shares rose for seven straight trading days, rising 6.2% (+$1.21). It saw one of its worst periods between July 6, 2011 and July 18, 2011 when shares fell for nine straight trading days, falling 5.5% (-$1.13).

Shares of Merck & Co Inc. (NYSE:MRK) are among the most actively traded stocks in the market. They have a dollar volume today of $104.4 million, based on a current price of $31.59 (-82 cents) and 3.3 million shares being traded.

Stock Price Performance: From July 8, 2011, to September 2, 2011, the stock price had fallen $3.75 (-10.4%) from $36.12 to $32.37. The stock price saw one of its best stretches over the last year between April 21, 2011 and May 4, 2011 when shares rose for nine straight trading days, rising 7.4% (+$2.49). It saw one of its worst periods between July 21, 2011 and August 4, 2011 when shares fell for 11 straight trading days, falling 12.9% (-$4.67).

Shares of Abbott Laboratories (NYSE:ABT) have a dollar volume of $98.4 million based on a current price of $49.92(-$1.15) and two million shares traded.

Stock Price Performance: From July 8, 2011, to September 2, 2011, the stock price had fallen $1.81 (-3.4%) from $52.85 to $51.04. The stock price saw one of its best stretches over the last year between March 25, 2011 and April 4, 2011 when shares rose for seven straight trading days, rising 4.6% (+$2.18). It saw one of its worst periods between July 22, 2011 and August 2, 2011 when shares fell for eight straight trading days, falling 5.2% (-$2.75).

Shares of Bristol-Myers Squibb Company (NYSE:BMY) are among the most actively traded stocks in the market. There are 5.5 million shares trading hands at $28.95(-6 cents), making up a dollar volume of $160.4 million.

Stock Price Performance: From August 5, 2011, to September 2, 2011, the stock price had risen $1.58 (5.8%) from $27.43 to $29.01. The stock price saw one of its best stretches over the last year between June 27, 2011 and July 7, 2011 when shares rose for eight straight trading days, rising 4.4% (+$1.23). It saw one of its worst periods between January 3, 2011 and January 11, 2011 when shares fell for seven straight trading days, falling 2.5% (-63 cents).